## **Core Concept**
The question tests knowledge of anaesthetic agents and their safety profiles in patients with renal failure. Renal failure necessitates careful selection of anaesthetic agents to avoid further kidney damage. The primary concern is the potential for nephrotoxicity or accumulation of toxic metabolites.

## **Why the Correct Answer is Right**
Methoxyflurane is a potent inhalational anaesthetic agent that is metabolized to inorganic fluoride ions, a known nephrotoxin. High levels of fluoride ions can cause renal damage, making methoxyflurane particularly risky for patients with renal failure. The metabolism of methoxyflurane results in the release of fluoride ions, which can exceed the threshold for nephrotoxicity, especially in patients with compromised renal function.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Halothane is metabolized by the liver and does not have a significant nephrotoxic metabolite. While it has its own set of concerns, such as hepatitis, it is not specifically contraindicated in renal failure due to nephrotoxicity.
* **Option B:** Isoflurane is another inhalational agent that undergoes minimal metabolism, and its metabolites are not nephrotoxic. It is considered safe in patients with renal failure.
* **Option D:** Sevoflurane can produce compound A, a potential nephrotoxin, when degraded by soda lime. However, the risk is more relevant to low-flow anesthesia circuits and prolonged use. It is not as directly contraindicated in renal failure as methoxyflurane.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that methoxyflurane's use has significantly declined due to its nephrotoxic potential. For patients with renal failure, anaesthetic choices should prioritize agents with minimal nephrotoxic metabolites. Always consider the metabolism and side effects of anaesthetic agents in the context of renal function.

## **Correct Answer:** . Methoxyflurane